Longitudinal Evaluation Of The First Mutant Huntingtin PET Radioligand As A Marker For mHTT Lowering Therapies For Huntington's Disease

被引：0
|
作者：
Bertoglio, D. [1 ]
Verhaeghe, J. [1 ]
De Lombaerde, S. [1 ,2 ]
Zajicek, F. [1 ]
Vasilkovska, T. [1 ]
Miranda, A. [3 ]
Gaertner, A. [4 ]
Huscher, B. [4 ]
Kakoulidou, A. [4 ]
Cardaun, I. [4 ]
Cornelius, A. [4 ]
Schwagarus, T. [4 ]
Van der Linden, A. [1 ]
Stroobants, S. [1 ,2 ]
Wang, Y. [5 ]
Skinbjerg, M. [5 ]
Dominguez, C. [5 ]
Khetarpal, V. [5 ]
Liu, L. [5 ]
Munoz-Sanjuan, I. [5 ]
Bard, J. [5 ]
Staelens, S. [1 ]
机构：
[1] Univ Antwerp, Antwerp, Belgium
[2] Antwerp Univ Hosp, Edegem, Belgium
[3] Univ Antwerp, Antwerp, Belgium
[4] Evotec SE, Hamburg, Germany
[5] CHDI Management CHDI Fdn, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0346
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients
    van Roon-Mom, Willeke M. C.
    Roos, Raymund A. C.
    de Bot, Susanne T.
    NUCLEIC ACID THERAPEUTICS, 2018, 28 (02) : 59 - 62
  • [22] Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease
    Wellington, CL
    Ellerby, LM
    Gutekunst, CA
    Rogers, D
    Warby, S
    Graham, RK
    Loubser, O
    van Raamsdonk, J
    Singaraja, R
    Yang, YZ
    Gafni, J
    Bredesen, D
    Hersch, SM
    Leavitt, BR
    Roy, S
    Nicholson, DW
    Hayden, MR
    JOURNAL OF NEUROSCIENCE, 2002, 22 (18): : 7862 - 7872
  • [23] Characterization of the novel mutant-huntingtin-aggregate-directed PET radioligand [11C]CHDI-009R in a mouse model of Huntington's disease
    Zajicek, F.
    Verhaeghe, J.
    De Lombaerde, S.
    Miranda, A.
    Stroobants, S.
    Skinbjerg, M.
    Wang, Y.
    Munoz-Sanjuan, I.
    Dominguez, C.
    Khetarpal, V.
    Bard, J.
    Liu, L.
    Bertoglio, D.
    Staelens, S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 9 - 10
  • [24] Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Z Tan
    W Dai
    T G M van Erp
    J Overman
    A Demuro
    M A Digman
    A Hatami
    R Albay
    E M Sontag
    K T Potkin
    S Ling
    F Macciardi
    W E Bunney
    J D Long
    J S Paulsen
    J M Ringman
    I Parker
    C Glabe
    L M Thompson
    W Chiu
    S G Potkin
    Molecular Psychiatry, 2015, 20 : 1286 - 1293
  • [25] Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
    Bertoglio, Daniele
    Bard, Jonathan
    Hessmann, Manuela
    Liu, Longbin
    Gaertner, Annette
    De Lombaerde, Stef
    Huscher, Britta
    Zajicek, Franziska
    Miranda, Alan
    Peters, Finn
    Herrmann, Frank
    Schaertl, Sabine
    Vasilkovska, Tamara
    Brown, Christopher J.
    Johnson, Peter D.
    Prime, Michael E.
    Mills, Matthew R.
    Van der Linden, Annemie
    Mrzljak, Ladislav
    Khetarpal, Vinod
    Wang, Yuchuan
    Marchionini, Deanna M.
    Skinbjerg, Mette
    Verhaeghe, Jeroen
    Dominguez, Celia
    Staelens, Steven
    Munoz-Sanjuan, Ignacio
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (630)
  • [26] Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Tan, Z.
    Dai, W.
    van Erp, T. G. M.
    Overman, J.
    Demuro, A.
    Digman, M. A.
    Hatami, A.
    Albay, R.
    Sontag, E. M.
    Potkin, K. T.
    Ling, S.
    Macciardi, F.
    Bunney, W. E.
    Long, J. D.
    Paulsen, J. S.
    Ringman, J. M.
    Parker, I.
    Glabe, C.
    Thompson, L. M.
    Chiu, W.
    Potkin, S. G.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1286 - 1293
  • [27] Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington's disease: the prospective HD-CSF study
    Rodrigues, F. Brogueira
    Byrne, L.
    Tortelli, R.
    Johnson, E.
    Wijeratne, P.
    Arridge, M.
    De Vita, E.
    Alexander, D. C.
    Tabrizi, S. J.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 104 - 104
  • [28] Longitudinal Dynamics of Mutant Huntingtin and Neurofilament Light in Huntington's Disease: the Prospective HD-CSF Study
    Rodrigues, Filipe Brogueira
    Byrne, Lauren M.
    Tortelli, Rosanna
    Johnson, Eileanoir B.
    Wijeratne, Peter A.
    Arridge, Marzena
    De Vita, Enrico
    Alexander, Daniel C.
    Tabrizi, Sarah J.
    Schobel, Scott
    Scahill, Rachael I.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 5 - 5
  • [29] Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington's disease: the prospective HD-CSF study
    Rodrigues, F.
    Byrne, L.
    Tortelli, R.
    Johnson, E.
    Wijeratne, P.
    Arridge, M.
    De Vita, E.
    Alexander, D.
    Tabrizi, S.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, E.
    MOVEMENT DISORDERS, 2020, 35 : S101 - S102
  • [30] Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1
    van der Bent, M. Leontien
    Evers, Melvin M.
    Valles, Astrid
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 141 - 160
12345